Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $7.41M | $24.21M | -69.39% |
Operating Income | $-104.13M | $-98.93M | -5.26% |
Net Income | $-98.67M | $-96.46M | -2.29% |
EPS (Basic) | $-1.21 | $-1.33 | +9.02% |
EPS (Diluted) | $-1.21 | $-1.33 | +9.02% |
R&D Expense | $84.82M | $99.65M | -14.88% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $1.36B | $1.33B | +2.06% |
Current Assets | $1.12B | $1.08B | +3.57% |
Total Liabilities | $446.31M | $570.85M | -21.82% |
Current Liabilities | $187.22M | $219.93M | -14.87% |
Stockholders' Equity | $913.49M | $761.51M | +19.96% |
Cash & Equivalents | $287.85M | $249.77M | +15.24% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-99.75M | $-109.81M | +9.17% |
Investing Cash Flow | $-53.46M | $25.45M | -310.07% |
Financing Cash Flow | $2.9M | $98.42M | -97.06% |
D&A | $5.43M | $4.65M | +16.87% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -1405.3% | -408.7% | -996.63% |
Net Margin | -1331.6% | — | — |
ROE | -10.8% | — | — |
ROA | -7.3% | — | — |
Current Ratio | $5.991 | — | — |
Debt to Equity | $0.489 | — | — |
Other companies in Biotechnology